逆転したミトコンドリアに対する失敗した反応としての癌

John Hartung¹

¹Department of Anesthesiology, State University of New York Downstate Health Sciences University, Brooklyn, NY, 11203, USA.

Experimental cell research

|August 22, 2025

まとめ

ミトコンドリア間の細胞内競争に焦点を当てたシリル・ダーリングトンの1948年の癌理論が再考される. この研究は野生型のミトコンドリアとその遺伝子の潜在的治療法を示唆しています

科学分野:

細胞生物学
腫瘍学
遺伝学

背景:

ミトコンドリアは細胞の"パワーハウス"と呼ばれ細胞の代謝と機能に重要な役割を果たします
シリル・ダーリングトンの1948年の"プラズマゲン理論"では,がんはミトコンドリアの広範な理解より前の細胞内競争から発生すると提案した.
最近の発見はミトコンドリアの複雑な役割と能力を強調しダーリントンの理論の再評価を正当化しています

研究の目的:

現代のミトコンドリア研究に照らしてシリル・ダーリングトンの"プラズマゲン理論"を再考する
ミュータント型とワイルド型ミトコンドリアの間の細胞内競争ががんの主要な原因であるという仮説を検証する.
ミトコンドリアの遺伝学と機能に基づいた癌の治療戦略を提案する.

主な方法:

歴史的科学文献のレビュー,特にシリル・ダーリングトンの"癌の起源のプラズマゲン理論"
ミトコンドリアの遺伝学,機能,がん発症における役割に関する現代的な研究の分析.
正常と変異したミトコンドリアの細胞内競争ダイナミクスの理論モデル化.

主要な成果:

ダーリントンの理論はミトコンドリアに直接言及していないが,がんにおけるミトコンドリアの役割の現在の理解と一致している.
ミトコンドリアの機能障害と突然変異が様々な癌に関わっているという証拠があります
ミトコンドリア集団間の細胞内競争は腫瘍形成を促す可能性があります.

結論:

ダーリントンの"プラズマゲン理論"は癌の起源を理解するための有効な枠組みを提供している.
将来の癌の治療には,ミトコンドリア遺伝子を標的とし,野生型のミトコンドリア集団を回復する治療介入が含まれるかもしれません.
ミトコンドリアの遺伝学とがんにおけるその役割に関するさらなる研究は新しい治療法の開発に不可欠です

キーワード:

アポトーシス癌について進化について実験ヘテロプラズマホモプラズミックミトコンドリアミトコンドリア移転ミトファジー生殖競争リバーシブルな反応

さらに関連する動画

07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

7.0K

11:32

Analytical Determination of Mitochondrial Function of Excised Solid Tumor Homogenates

Published on: August 6, 2021

2.8K

関連する概念動画

02:53

Adaptive Mechanisms in Cancer Cells

5.9K

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

5.9K

01:46

Electron Transport Chain: Complex I and II

15.0K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

15.0K

02:56

Treatment Resistant Cancers

3.4K

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

3.4K

02:40

Cancer Stem Cells and Tumor Maintenance

5.0K

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

5.0K

02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.7K

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

12.7K

02:18

Cancer

49.5K

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.